Wall Street’s Top Analysts Upgrades, Downgrades & Initiations
$ABT, $DLPH, $NFLX, $DIS
Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of Wall Street’s Top analysts outlook for Key issues for Wednesday, as follows:
Abbott Laboratories (NYSE:ABT) analysts raised to Overweight from Neutral and the price target was raised to 65 from 60 at JPMorgan, citing solid fundamentals and organic growth and new product launches. Morgan Stanley raised it to Overweight from Neutral and the price target was raised to 67 from 60, citing a device pipeline bringing accelerated growth along with deal synergies driving earnings. Abbott has a 52-wk trading range of 38.34 – 57.77 and has a consensus analyst price target at 61.88.
Delphi Technologies PLC (NYSE:DLPH) was started as Outperform and assigned a 73 price target at BMO Capital Markets. The consensus price target is 59.54.
Netflix Inc. (NASDAQ:NFLX) analysts raised to Outperform from Neutral and the price target was raised to 220 from 200 at Macquarie. This is a broad realignment of media coverage citing gains ahead for Netflix. The 52-wk trading range is 124.31 – 204.38, and the consensus price target is 215.03.
Walt Disney Co. (NYSE:DIS) was raised to Outperform from Neutral and the price target was raised to 125 from 112 at Macquarie. The call is bolstered by its capability for distribution ahead in a broad media realignment. Disney has a 52-wk trading range of 96.20 – 116.10 and a consensus analyst target of 112.11.
Latest posts by HEFFX Australia (see all)
- Tesla (NASDAQ:TSLA) Stock Technicals and Charts - November 27, 2020
- Amazon (NASDAQ:AMZN) Stock Moving Up, Stock Analysis and Charts by Metastock - November 27, 2020
- Should You Be Buying Apple (NASDAQ:AAPL) Stock Right Now? - November 27, 2020